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Abstract
In this study we have reported the in vivo proteomic changes during Japanese Encephalitis Virus (JEV) infection in
combination with in vitro studies which will help in the comprehensive characterization of the modifications in the host
metabolism in response to JEV infection. We performed a 2-DE based quantitative proteomic study of JEV-infected mouse
brain as well as mouse neuroblastoma (Neuro2a) cells to analyze the host response to this lethal virus. 56 host proteins were
found to be differentially expressed post JEV infection (defined as exhibiting $1.5-fold change in protein abundance upon
JEV infection). Bioinformatics analyses were used to generate JEV-regulated host response networks which reported that
the identified proteins were found to be associated with various cellular processes ranging from intracellular protein
transport, cellular metabolism and ER stress associated unfolded protein response. JEV was found to invade the host protein
folding machinery to sustain its survival and replication inside the host thereby generating a vigorous unfolded protein
response, subsequently triggering a number of pathways responsible for the JEV associated pathologies. The results were
also validated using a human cell line to correlate them to the human response to JEV. The present investigation is the first
report on JEV-host interactome in in vivo model and will be of potential interest for future antiviral research in this field.
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Introduction
Viral entry, replication, and assembly are dynamic processes
that involve numerous host-pathogen interactions. Traditional
antiviral drug-discovery approaches were directed against virally
encoded enzymes that are essential for viral replication but have
failed to be effective. Viruses have the inherent capacity to rapidly
mutate and become resistant to even the most potent of drugs
because of their low-fidelity replication mode [1]. Hence, the focus
of antiviral research is shifting towards manipulating the host
antiviral response by targeting cellular enzymes or cofactors
required for the viral life cycle.
Viruses are known to enter host cells via various receptor-
mediated/endocytosis-mediated routes and replicate in the cyto-
plasm of infected cells. During the process, they invade various
host systems to promote their own replication and evade the
system’s immune response. The onset of the viral infection triggers
a series of changes in the host microenvironment to ensure the
clearance of the pathogen and removal of infected cells. It is now
thus well recognized that identification of host proteins of interest,
after additional functional validation, may lead to new discoveries
regarding host-virus interactions.
In the recent years proteomics- based studies have been
significant in providing insights into how the host protein
expression profile is altered during viral infection and hence
fostered a new branch of study known as Viral Proteomics [2,3].
Systems biology is another budding field of science which
incorporates mathematical and bio-informatics tools to understand
biological systems. There have been recent reports which analyze
the viral proteomic data using systems biology in order to predict
host- pathogen interactions [4–6].
Japanese encephalitis (JE), is one of the most prevalent forms of
viral encephalitis worldwide, affecting mostly children and is
responsible for around 15,000 deaths annually [7]. It is caused by
a mosquito-borne flavivirus called Japanese encephalitis virus
(JEV) which is a positive sense single stranded RNA virus that
causes extensive neuronal death. JEV infection manifests with
fever, headache, vomiting, signs of meningeal irritation and altered
consciousness leading to high mortality and neurological sequelae
in some of those who survive [8]. Recent reports have shown that
this disease is spreading to other distant parts of the world,
contrary to common belief that this disease is restricted to parts of
Asia, thus increasing the need for a better understanding of JEV
pathogenesis which may help in the development of different
preventive strategies and new therapeutic interventions [9].
Proteomic study of host response to West Nile Virus (which is
the nearest kin to JEV) infection in Vero cells has reported most of
the altered host proteins to be involved in transcription/translation
processes, alteration of the cytoskeleton networks, stress cellular
response, and apoptotic pathways [10]. In a recent study of JEV
infection in HeLa cells, Zhang et al. have reported IFITM3,
RANBP2, SAMD9, and VAMP8 as potential antiviral factors with
roles in JEV infection [3]. However, to the best of our knowledge,
no such analysis has been carried out in any in vivo model for JEV
infection.
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Although a number of studies have been carried out to study the
host response to viruses from the family flaviviridae, most of them
have been limited to in vitro models which may not necessarily
provide an insight into the actual host environment [10,11]. This
study has been designed to characterize the modifications induced
in the host proteome by employing 2DE-MS approach in response
to JEV infection in mouse model. In the present investigation we
restricted our study to JEV-infection in neuronal cells. In total, 56
proteins were identified to be differentially expressed in brain and
neurons. Most of the differentially regulated proteins were found
to be associated with cellular metabolism followed by stress
response, regulation of apoptosis, protein transport and localiza-
tion and stabilizing cytoskeletal interactions. As we have used an in
vivo mouse model in this study, the host response to JEV infection
could be a cumulative effect of several factors including expression
and transport of molecules from different tissue compartments,
secretion, and/or post translational modifications.
In order to elucidate the interacting partners of the proteins
differentially expressed in our proteomic analysis and establish a
host-viral interactome model we applied bio-informatics tools.
Bioinformatics analysis carried out using the NeuroDNet database
for constructing and analyzing neurodegenerative disease associ-
ated gene networks revealed the interactions between the viral
proteins and the host proteome (proteins which were differentially
expressed in our case) and helped us to corroborate our findings.
Materials and Methods
Ethics Statement
All animal experiments were approved by the Institutional
Animal and Ethics Committee of the National Brain Research
Centre (approval no. NBRC/IAEC/2011/66). The animals were
handled in strict accordance with good animal practice as defined
by the Committee for the Purpose of Control and Supervision of
Experiments on Animals, Ministry of Environment and Forestry,
Government of India.
Cells and viruses
Cells Mouse neuroblastoma (Neuro2a) purchased from Na-
tional Centre For Cell Science, Pune, India and human
neuroblastoma cell line (SHSY-5Y) (kind gift from Dr. Steve
Levison, University of Medicine and Dentistry, New Jersey, USA,
obtained from ATCC) were grown at 37uC in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 3.7%
sodium bi-carbonate (NaHCO3), 10% fetal bovine serum and
penicillin/streptomycin. All the reagents related to cell culture
were obtained from Sigma (St. Louis, USA), unless otherwise
stated. Cells were maintained as monolayers in 10% CO2 and
were passaged by trypsinization 2 to 3 times each week.
Viruses
GP78 strain of JEV was propagated in suckling BALB/c mice
and their brains were harvested when pathological symptoms were
observed. Virus titrations were conducted and quantified as
described earlier [12].
JEV infection in mouse model
Adult BALB/c mice (4–6 weeks) were used in all experimental
procedures. Mice were randomly assigned to two groups consisting
of 4 animals each: Mock-infected control (Control) and JEV
infected (JEV) (groups did not have sexual bias). Animals were
injected with 36105 p.f.u. of JE virus of strain GP78 through tail
vein while the control animals received phosphate buffered saline
(PBS). Animals were sacrificed on fifth day post-infection when
they started showing acute symptoms of JE including restriction of
movements, limb paralysis, poor pain response, whole body
tremor, pilo-erection, and hind limb paralysis. Tissues were snap
frozen in liquid nitrogen and kept in 280uC till use.
Infection of mouse neuroblastoma cell line with JE virus
Mouse neuroblastoma Neuro2a cells (Neuro2a) were plated at a
density of 36106 cells per plate and cultured in serum containing
media until cells reached 70–80% confluency. Cells were then
either mock-infected or infected with JEV (4.46109 pfu/mL) at
multiplicity of infection (MOI) of 5 for 1.5 h. Cells were then
washed twice with sterile 16PBS to remove non-internalized virus
and were incubated for 36 h in serum free media.
Protein extraction from brain tissue and neuroblastoma
cell line
The brain tissues (,0.4 g) were thawed on ice and homoge-
nized using Ultra-turrax T8 homogenizer (IKA-Werke GmbH &
Co. KG, Germany) in 500 ml solubilization buffer containing 8M
urea, 2% (w/v) CHAPS, 0.2% sodium orthovanadate and 16
concentration of protease inhibitor cocktail for mammalian cells
and tissue extracts (Sigma Aldrich, USA). The supernatant was
collected by centrifugation and subjected to three pulses of
sonication on ice followed by centrifugation at 20,0006 g for
30 min at 4uC for the recovery of total soluble proteins. Protein
extraction from Neuro2a cells was carried out in a similar manner.
Protein concentration was quantified in supernatants by Bradford
Protein Assay kit (Bio-Rad, USA) as per manufacturer’s instruc-
tions and the extraction procedure was carried out according to
[13].
Two dimensional gel electrophoresis (2-DE)
2-DE was performed as described earlier [14]. The protein
pellet was resuspended in sample rehydration buffer (8 M urea,
2% w/v CHAPS, 15 mM DTT and 0.5% v/v IPG buffer pH 3–
10). The isoelectric focusing was performed using immobilized pH
gradient (IPG) strips (Bio-Rad, USA). IPG strips of 7 cm size with
a pH range from 4.0–7.0 and 5.0–8.0 were used for all the
experiments. For the first dimension 500 mg of protein samples in
150 ml of rehydration solution was used to passively rehydrate IPG
strips overnight. The proteins were then focused for 10000 VHr at
20uC under mineral oil on a Protean i12TM IEF Cell (Bio-Rad,
USA). After focusing, the strips were incubated for 10 min, in 2 ml
of equilibration buffer I (6 M urea, 30% w/v glycerol, 2% w/v
SDS and 1% w/v DTT in 50 mM Tris/HCl buffer, pH 8.8)
followed by equilibration buffer II (6 M urea, 30% w/v glycerol,
2% w/v SDS and 4% w/v iodoacetamide in 375 mM Tris/HCl
buffer, pH 8.8). After the equilibration steps the strips were
transferred to Tris glycine SDS-PAGE where proteins were
separated on 10% and 14% acrylamide gels for the second
dimension by the method of Blackshear [15].
Protein visualization and image analysis
Protein spots were visualized by staining with Coomassie
Brilliant Blue G-250. Gel images were captured by LI-COR
odyssey infra-red imager (LI-COR Biosciences, USA). Four
biological replicates each with two analytical replicate (n = 8)
images per dataset (mock-infected control versus JEV infected)
were used for automatic spot detection using PD Quest 2D
Analysis Software (Hercules, CA, USA). Spot intensities were
normalized by total valid spot intensities and mean of values from
duplicate analytical gels from four biological replicates were
subjected to paired t-test analysis using GraphPad Prism software.
Host Response to Japanese Encephalitis Virus
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Protein spots showing altered expression between control and
experimental groups (|ratio|$1.5, p$0.05) were marked and
excised.
In gel protein digestion
The in gel tryptic digestion of the protein spots was carried out
as described previously [16]. Briefly, gel pieces excised from 2-DE
gels were destained at room temperature with 200 mL 50%) ACN/
50 mM NH4HCO3 for 1 h. The gel pieces were reduced (0.16%
DTT in 50 mM NH4HCO3), alkylated (2% iodoacetamide in
50 mM NH4HCO3), dried and then digested with 100 ng trypsin
(Sigma-Aldrich, USA) in 50 mM NH4HCO3 overnight at 37uC.
Peptides were extracted with 50% acetonitrile and 0.1% trifluoro-
acetic acid (TFA), dried, and resuspended in 0.5% TFA before MS
analysis.
Identification of protein spots by tandem mass
spectrometry
Spots showing differential expression in brain and Neuro2a cells
were analyzed at the central instrumental facility at the Delhi
University South Campus and identified by Applied Biosystem
4800 plus MALDI TOF/TOF Analyzer (AB Sciex, USA) as
previously described. For MALDI-TOF mass spectrometry, 1 ml
of the digest was mixed with 2 ml of the matrix solution (a-cyano-
4-hydroxycinnamic acid in 80% [vol/vol] acetonitrile and 0.1%
[vol/vol] trifluoroacetic acid [TFA]), and 1 ml of this mixture was
deposited onto the MALDI target. The spectrum was obtained in
the mass range of 500 to 4,000 Da and was calibrated using a
calibration mixture containing angiotensin I, Substance P,
adrenocorticotropin(1–17) [ACTH(1–17)], ACTH(18–39), and
somatostatin [17].Spectra were analyzed with MASCOT se-
quence-matching software from Matrix Science. The peak list was
searched against the taxonomy group Mus musculus at non-
redundant protein sequence database of NCBI with 144127
sequence entries. Search parameters were as follows: trypsin
digestion with one missed cleavage, variable modifications
(oxidation of methionine and carbamidomethylation of cysteine),
and the peptide mass tolerance of 50 ppm for precursor ion and
mass tolerance of 60.6 Da for fragment ion with +1 charge state.
Validation of proteomic results by Immuno-blot analysis
Total protein was extracted from brain tissues or mouse
neuroblastoma cells (control and JEV infected) as described above.
Protein concentration was quantified in supernatants by Bradford
Protein Assay kit (Bio-Rad, USA) as per manufacturer’s instruc-
tions. Equivalent amounts of the tissue lysates (50 mg) were
separated on 10% SDS-PAGE and then transferred to a
nitrocellulose membrane followed by blocking. The blots were
incubated with respective primary antibodies (Abcam,Cambridge,
UK) at 4uC overnight at dilutions recommended by the
manufacturer as mentioned in Table S1. After extensive washes
in PBST, the blots were incubated with appropriate (mouse or
rabbit specific) secondary antibodies (1:5000; Vector laboratories,
USA). The blots were again rinsed in PBST and processed for
development using an ECL Immuno-blot kit (Milipore, India).
The images were captured and analyzed using Chemigenius
Bioimaging System (Syngene, Cambridge, UK). The blots were
stripped and reprobed with anti-b-tubulin (1:1000; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) to determine equivalent
loading of samples. Quantitative changes were determined by
densitometric analysis of the blots.
Immunostaining
Neuro2a cells were cultured in 4-well chamber slides and were
either mock- infected or infected with JEV as described above.
The cells were incubated for 36 h and then fixed in 4%
paraformaldehyde followed by blocking with 5% BSA solution.
The cells were then incubated overnight at 4uC with primary
antibodies against JEV Nakayama strain (1:100; Chemicon, USA).
Following incubation, the cells were washed and incubated with
FITC-conjugated secondary antibodies. Final washes were
followed by mounting with 49-6- diamidino-2-phenylindole
(DAPI, Vector laboratories Inc., CA, USA). Images were obtained
using Zeiss Axioplan 2 upright digital microscope (Zeiss,
Germany).
Immunohistochemistry
JEV infected and age matched control BALB/c mice in sets of
three were perfused transcardially with 16PBS and whole brains
isolated were fixed with 4% paraformaldehyde (PFA) in 16 PBS
for 24 h at 4uC and subsequently kept in 30% sucrose for
additional 24–48 h at 4uC. The brains were then processed for
cryostat sectioning and the sections were stained for selected
proteins and, a neuronal marker NeuN. Briefly, the cryostat
sections were washed with 16 PBS and processed for antigen
retrieval by incubating at 70uC for 1 h in antigen unmasking
solution (Vector laboratories). The sections were then washed with
16PBS and blocked for 1.5 h with 5% BSA in 16PBS. Neurons
were labeled with mouse anti-NeuN antibody (1:500; Chemicon,
USA), along with mouse/rabbit specific antibodies (1:500; Abcam
Cambridge, UK) by incubating the sections overnight at 4uC.
After five washes with 16 PBS, the sections were incubated with
horse anti-mouse Fluorescein Isothiocyanate (FITC, 1:250; Vector
Laboratories) for NeuN and goat anti-rabbit Alexa Fluor 594
(1:1000; Molecular Probes, Oregon, USA) for selected antibodies
for 1 h. The slides were then mounted with mounting medium
containing DAPI (Vector laboratories). The images were captured
with Zeiss Axioplan 2 upright digital microscope (406 magnifi-
cation; Zeiss, Germany).
Analysis of Protein-Protein Interaction Networks
For protein-protein interaction analysis, genes were annotated
with homologous human genes using human genotype terms and
codes (www.ncbi.nlm.nih.gov/genbank/). The interaction net-
work for observed genes were obtained by using human protein
interaction information provided by NeuroDNet [18] and
visualized using Cytoscape [19]. The biological processes and
biochemical pathways used in the analysis in this paper were
obtained from the Gene Ontology (GO) [20], Kyoto Encyclopedia
of Genes and Genomes (KEGG) [21] and Reactome [22] Pathway
database. Statistically significant clusters from biological processes
and biochemical pathways of genes into sub-graphs were identified
using GO enrichment analysis plugin BiNGO [23] and Gene set
enrichment analysis (GESA) [24] tool. Statistically significant
clusters were found in the network by applying Hypergeometric
test with Benjamini & Hochberg False Discovery Rate (FDR)
correction [25]. The functional clusters of genes that were found to
be significant in the experiments were used to construct a
perturbed interaction network. The network consisted of viral
and human protein interactions. The experimentally observed
proteins overlapped with human protein interaction information
with directional signal transduction and metabolic pathways.
Based on the derived data, JEV pathogenesis network was
reconstructed that shows several closely related genes networked
with the genes found in the JEV infection analysis. The interaction
Host Response to Japanese Encephalitis Virus
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information between JEV proteins and human proteins was
obtained from the literature.
Statistical analysis
The experimental data between two groups were analyzed using
student’s t-test, and data among several groups were analyzed by
one-way ANOVA by GraphPad Prism 5 software. A p value,0.05
was considered significantly different. All results are presented as
mean 6 SD from at least three independent experiments, unless
otherwise stated.
Results
Global host proteome response post- JEV infection in
vivo and in vitro models
JEV modulated host proteins were identified by proteomic
analyses of JEV-infected mouse brain and JEV-infected Neuro2a
cells comparing with their mock-infected controls. For brain
tissues, the proteins were separated at different pH ranges of 4.0–
7.0 and 5.0–8.0 and different SDS PAGE gel concentrations of 10
and 14% in order to ensure total coverage of the host proteome.
For Neuro2a cells, the proteins were separated at pH 4.0–7.0.
With the use of PD Quest software, 2-DE gel images for control
versus JEV infected tissues were quantitatively analyzed as shown
in Fig. 1, 2 & 3. A total of 165 and 51 protein spots were matched
on 2-DE gels between control and treated brain and Neuro2a
samples respectively. In brain total proteome 50 spots were found
to be differentially regulated out of which 41 could be successfully
identified. Among those, 11 spots were significantly up regulated
(ratioJEV/control$|1.5|, p,0.05, spots shown in Fig. 2) while
the rest were found to be down regulated. Fifteen protein spots
from Neuro2a showing significant changes in intensity ratio were
observed. (4 spots were up-regulated and 11 spots were down-
regulated, (ratioJEV/control$|1.5|, p,0.05, spots shown in
Fig. 3).
The observed MW and pI values of the protein spots on the 2-
DE gels were compared with the theoretical MW and pI values of
corresponding proteins. Most of the experimental values were
found to be close to theoretical values, indicating unambiguous
identification (Table S2). Certain differences in theoretical and
experimental values were observed for some of the identified
proteins which might be a result of post-translational proteolytic
processing and modification whereas a difference in the pI values
might be attributed to the cleavage of alkaline regions and
phosphorylation of multiple residues.
Differentially regulated proteins related to metabolism,
protein folding and cytoskeleton post-JEV infection
All protein spots showing differential expression of 1.5 fold or
greater (p,0.05) were excised, trypsin digested and identified by
MALDITOF/TOF MS and MS/MS analysis. Table S2 corre-
sponds to the spots in Fig. 1, 2 & 3 and lists the protein names;
Figure 1. Proteomic Analysis of brain tissue lysate post-JEV infection. Equal amount of total protein from brain tissue lysates were
separated on (A) an immobilized linear pH gradient IPG strips (4.0–7.0) (B) pH gradient IPG strips (5.0–8.0) and then in the second dimension on 10%
SDS-PAGE and (C) 14% SDS-PAGE. Spots showing differential expression were marked and excised, and identified by MALDITOF/MS and database
searches. The spots are labeled on the gel according to the numbers presented in Table S1.
doi:10.1371/journal.pone.0090211.g001
Host Response to Japanese Encephalitis Virus
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MOWSE score, matched peptides and sequence coverage of
identified proteins; Mr and pI values; and fold changes between
control and JEV infected group. Among the differentially
expressed proteins in response to JEV infection, alfa fetoprotein,
serum albumin precursor, and peroxiredoxin 6 isoforms were
found to be the most abundant up regulated spots (Fig. 1, Table
S2). In addition, brain tissue also showed over expression of
aldolase C and proteasome subunit alpha type-1 while BiP,
nucleobindin1 and heterogeneous nuclear ribonucleoprotein H
were found to be over expressed in Neuro2a cells. Very few of the
identified proteins which include gamma actin, calreticulin
precursor and heat shock protein-8 were found common to both
the brain lysate and Neuro2a cells which were used in the study to
mimic host neuronal response to the neurotropic virus. We
observed down regulation of various proteins which are involved
in metabolism and protein transport (Table S2). The proteins
identified could be functionally classified into various groups
(http://ca.expasy.org/), including those involved in intracellular
protein transport (VCP, CALR, ERP29 VIM, ACTG1, PRDX4,
PDIA6), protein localization (ACTG1, AFP, CAPZB), stress
induced response (STIP1, HSPA8, UCHL1, PSMA1, CCT5)
and cellular metabolism (PDHB, PRDX6, LDHB, ALDOC,
YWHAG, GAPDH, PRDX6, PDXP, CKB, ENO2), nuclear
transport (NPM1, CALR, NUCB1), regulation of apoptosis
(HSP90B1, HSPA5, HSPA8, CALR,ATP5B, IDH3A) and ER
stress response (HSP90B1, HSPA5, HSPA8, CALR).
Validation studies by Immuno-blot analysis and
Immunohistochemistry
The proteomic results were validated by Immuno-blot analysis
using specific commercially available antibodies against differen-
tially expressed proteins. Immuno-blot data confirmed JEV
induced over-expression of aldolase C, ERP29 and proteasome
subunit alpha type-1 in brain tissue; and BiP, nucleobindin and
heterogeneous nuclear ribonucleoprotein H over-expression in
Neuro2a cells (Fig. 4). Antibody against the ‘‘housekeeping’’
protein, b tubulin was used as loading control to normalize the
quantitative data of Immuno-blot analysis. The presence of virus
in brains of JEV-infected animals as well as cells was confirmed by
immunofluorescence using antibodies specific to JEV strain
Nakayama (Fig. 5). The proteomic results were further reinforced
with the help of immunohistochemistry using specific antibodies
against randomly selected proteins belonging to different func-
tional categories. The differential expression of the selected
proteins in the cortical neurons could be distinctly visualized
(Fig. 6). Immunostaining of brain from JEV-infected animals
showed increased expression of ER stress associated proteins like
ERP29 and BiP and decrease expression of NSE, PRDX4, STIP1,
VCP, ERP57, and HSP60 that were co-localized with neuron-
specific marker NeuN, as compared to control.
Figure 2. Relative fold change in differentially expressed proteins in brain tissue post-JEV infection. Spot intensities were normalized
by total valid spot intensities and mean of values from duplicate analytical gels from four biological replicates were subjected to paired t-test analysis.
Protein spots showing altered expression between control and experimental groups (|ratio|$1.5, p,0.05) were marked and excised. Dark grey bars
indicate spots from mock infected control sample while light grey bars indicate JEV infected sample. * = p,0.05, #=p,0.01. Data represented are
means 6 SD of four independent experiments.
doi:10.1371/journal.pone.0090211.g002
Host Response to Japanese Encephalitis Virus
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The protein expression levels are modulated with disease
progression
Immuno-blot analysis was carried out in order to study the
expression of some selected proteins with the onset of infection
(Fig. 7). The expression of proteins was studied on 0 (control), 1, 3,
and 5 day post infection (d.p.i.). It was found that expression of
proteins like BiP, HSP70, and HSP90 showed a gradual increase
with the onset of infection. Peroxiredoxin 6 levels increased till
third d.p.i. but thereafter showed a consistent decline. HSP60,
stress induced phosphoprotein, T-complex protein 1 subunit
epsilon, Creatine Kinase B, Pyridoxal phosphate phosphatase
and ubiquitin carboxyl-terminal hydrolase PGP9.5 showed a
consistent decline post infection.
Proteome response to JEV infection in human neuronal
cells correlates to the murine model
Since Japanese encephalitis is a disease affecting the humans, we
have tried to correlate the proteomic results obtained in a mouse
model to that of humans. Immuno-blot analysis was carried out in
human neuroblastoma cells SHSY 5Y to confirm whether a
similar host response against JEV could be elicited in a human
model (Fig. 8). It was found that our observations in the human
model corroborates with that of our results in the mouse model.
We found that the proteins, BiP, HNRNPH1, NUCB1, HSP70
and aldolase C were up regulated in response to JEV while TCPE,
VCP, 14-3-3, ERP57 and nucleophosmin were down regulated.
Analysis of the host protein-protein interaction involved
in JEV infection
Based on our proteomic data, a systematic analysis of the host
protein-protein interactions was carried out using NeuroDNet
database. The proteins identified from the in vivo experiments were
associated with intracellular protein transport (VCP, CALR,
ERP29), protein localization (ACTG1, AFP, CAPZB), stress
induced response (STIP1, HSPA8, UCHL1, PSMA1, CCT5)
and cellular metabolism (PDHB, PRDX6, LDHB, ALDOC,
Figure 3. Differential protein expression in JEV infected Neuro2A cells. (A) A representative 2-DE gel of Neuroblastoma cell (Neuro2a) lysate
from mock-infected and JEV infected cells. Equal amount of total protein from cell lysates were separated on an immobilized linear pH gradient IPG
strips (4.0–7.0) and then in the second dimension on 10% SDS-PAGE. Spots showing differential expression were marked excised, and identified by
MALDITOF/MS and database searches. The spots are labeled on the gel according to the numbers presented in table S1. (B) Protein spots
representing relative fold change in expression in mouse neuroblastoma cell (Neuro2a) lysate.Spot intensities were normalized by total valid spot
intensities and mean of values from duplicate analytical gels from four biological replicates were subjected to paired t-test analysis. Protein spots
showing altered expression between control and experimental groups (|ratio|$1.5, p,0.05) were marked and excised. Dark grey bars indicate spots
from mock infected control sample while light grey bars indicate JEV infected sample. * = p,0.05. Data represented are means 6 SD of four
independent experiments.
doi:10.1371/journal.pone.0090211.g003
Host Response to Japanese Encephalitis Virus
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YWHAG, GAPDH, PRDX6, PDXP, CKB, ENO2). These
proteins were clustered in several pathways including Glycolysis/
Gluconeogenesis, pyruvate metabolism, Citric Acid (TCA) cycle,
destabilization of mRNA by AUF1 (hnRNP D0), ER Phagosome
pathway, antigen processing-cross presentation, regulation of
mRNA stability by proteins that Bind AU-rich elements. We
expanded the protein interaction network and observed that the
proteins were clustered in protein catabolism, ErbB1 downstream
signaling, ubiquitination of a protein, insulin receptor pathway,
mTOR signaling, ER-Phagosome pathway, assembly or disassem-
bly of microtubules, E-cadherin signaling, signaling from the
endoplasmic reticulum to the nucleus, ER-related stress response,
induction of apoptosis, and oxidative stress response (Fig. S1, S2 &
S6).
The proteins identified during the in vitro experiments were
found to be associated with nuclear transport (NPM1, CALR,
NUCB1), regulation of apoptosis (HSP90B1, HSPA5, HSPA8,
CALR, ATP5B, IDH3A), ER stress response (HSP90B1, HSPA5,
HSPA8, CALR), and intracellular protein transport (VIM,
ACTG1, PRDX4, PDIA6). These proteins were clustered in
several pathways including activation of chaperones, unfolded
protein synthesis, antigen processing and presentation, TCA cycle
and respiratory electron transport, auroraB pathway. We
expanded the protein interaction network and observed that the
proteins were clustered in protein folding, insulin receptor
signaling, endoplasmic reticulum to the nucleus signaling,
upregulation of the activity of a caspase, a6b1 and a6b4 integrin
signaling, p38 signaling mediated by MAPKAP kinases, TNFR1
signaling pathway, regulation of the actin cytoskeleton, involve-
ment of mitochondria in apoptotic signaling, antigen processing
and presentation, ER-related stress, assembly or disassembly of
microtubules, protein sequestration and stabilization(Fig. S1, S2
&S6). Protein interaction network analysis (Fig. S3& S4) helped us
to deduce the various interactions involved between the virus and
the host during JEV infection thereby regulating various metabolic
as well as apoptotic pathways. We found that the ER protein
folding and secreting machinery was the most perturbed by this
infection. Hence we also expanded the protein interaction network
involved in the unfolded protein response and found Hspa8,
Hsp90b1, Hspa5, Pdia6, Calr to be involved in unfolded protein
response (UPR) initiated by endoplasmic reticulum stress (Fig. S5).
Based on our analysis we proposed a mechanism of JEV infection
and the possible changes in the host cellular machinery as a result.
We deduced that during JEV infection the metabolic insult
reduces the ATP level through glycolysis, TCA cycle and oxidative
phosphorylation. The glucose sensors activate HSPA5 in ER and
ROS in mitochondria induce stress response. The viral proteins
inhibit the PERK and PKR response thus inducing the viral
protein translation and reduce the level of host cytosolic proteins
(Fig. 9). Table S3 shows the proteins selected for protein-protein
interaction analysis.
Figure 4. Validation of proteomic results using immunoblotting. Immunoblot of proteins showing altered expression in mouse brain with
respect to mock-infected control. b- Tubulin was used as loading control. Dark grey bars indicate spots from mock infected control sample while light
grey bars indicate JEV infected sample. Data represented are means 6 SD of three independent experiments. * = p,0.05.
doi:10.1371/journal.pone.0090211.g004
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Discussion
Viruses exploit the host cellular machinery to complete their life
cycle within their host. In our investigation an attempt has been
made to decipher the neuropathogenesis of Japanese Encephalitis
Virus (JEV) by studying the alterations made to the host proteome.
We have applied 2DE-MS based approach to elucidate the
proteomic changes in the host neurons post-JEV infection in a
mouse model. Our study was aided with bioinformatic analysis to
deduce the host- virus interactions and the various biological
pathways affected from the time of viral entry into the neurons.
JEV deploys a clathrin independent mechanism to infect
neuronal cells which requires dynamin and plasma membrane
cholesterol [26]. After endocytosis, the incoming JEV particles are
targeted to amphisomes for viral uncoating and an enhanced
autophagy increases the amounts of entered viral RNA, leading to
a higher level of viral protein expression and production.
Enhanced autophagy has also been shown to negatively regulate
the host innate antiviral response thus prolonging the viral
progeny inside the host cells [27]. JEV then traffics through
Rab5-positive early endosomes and release of the viral nucleo-
capsid occurs at the same stage. Various studies have proven that
the flaviviral replication is not restricted to the cytoplasm but
occurs in the host nucleus as well. There are strong evidences to
show that the major replicase proteins NS3 and NS5 of JEV are
localized within the nucleus during infection [28].
The viral core protein has been shown to co-localize with
nucleolar protein nucleophosmin (NPM1) and cause its redistri-
bution during infection suggesting a possible role in the
intracellular localization of the core protein and replication of
JEV [29]. NPM1 has been reported to function as a chaperone in
the viral chromatin assembly process in infected cells [30]. Our
investigation reports a decrease in the levels of NPM1 in JEV
infected neurons which can be hypothesized as an attempt by the
host neurons to arrest viral replication inside the cells. We also
observed a remarkable increase in the protein heterogeneous
nuclear ribonucleoprotein H (hnRNPH1) inside the neuronal cells
which acts as a splicing factor involved in the regulation of rpL3
alternative splicing [31]. HNRNPH1 has also been implicated in
assisting Hepatitis C virus replication [32]. Another protein
HNRNPA2 a member of the same family has been reported to
be involved in JEV replication [33]. These evidences suggest that
the high level of HNRPH1 in the neurons is the resultant of the
invasion of the host machinery by JEV in order to sustain its
replication.
Figure 5. Confirmation of JEV infection in both in vivo and in vitro models using JEV specific antibody. The onset of JEV infection was
confirmed by immunostaining of mouse brain sections and Neuro2a cells using JEV specific antibodies.
doi:10.1371/journal.pone.0090211.g005
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One of the pivotal weapons in the JEV arsenal is the cytoskeletal
disorganization. The present research reinforces the phenomena
by validating the alterations in various cytoskeletal proteins like f-
actin capping protein, gamma actin and tubulin and vimentin
post-JEV infection [34–37]. JEV infection is known to induce
microtubular rearrangement and redistribution in Vero cells [38].
In addition to this the cytoskeletal perturbation observed during
our investigation could also be a mode to facilitate the transport of
viral proteins inside the cells through the rough endoplasmic
reticulum (ER) and Golgi apparatus to the convoluted membrane,
which may serve as a reservoir for viral proteins during JEV
multiplication.
Previous reports claim targeting of mitochondria and alteration
of metabolic pathways for the production of macromolecular
substrates and energy during viral growth and replication. JEV
infection induces mitochondrial disruption, reactive oxygen species
[39] production and inflammation, which lead to apoptosis and
cytopathology [40]. Peroxiredoxins have been shown to combat
this oxidative insult by participating in antioxidant defense, redox
signaling, apoptosis control and kinase modulation. Out of these,
peroxiredoxin 6 (PRDX6) has been previously reported to be an
important antioxidant enzyme in human brain defenses and has
also been shown to play a neuroprotective role against hypoxia
induced damage [41].The same study has also reported a decline
in the levels of PRDX6 on prolonged exposure to ROS. These
reports further bolster our claims showing an increase in the
expression of PRDX 6 till 3 d.p.i. and a gradual decline in the
levels with disease progression. Another member of the same
family identified during the study in the Neuro2a lysate is
peroxiredoxin 4 (PRDX4) which is an endoplasmic reticulum
localized peroxiredoxin and is known to play an important role in
disulphide formation and can be associated with ER stress
response [42].
A tremendous assault on the host metabolic machinery was
observed with a consistent decline in the levels of various
metabolic enzymes like enolase, pyruvate dehydrogenase, lactate
dehydrogenase, isocitrate dehydrogenase, glyceraldehyde 3 phos-
phate dehydrogenase (GAPDH) commonly involved in glycolysis
and TCA cycle. Previous reports indicate that GAPDH interacts
with 39 ends of Japanese encephalitis virus RNA and co-localizes
with the viral NS5 protein suggesting a possible role in viral
replication [43]. Jaag et al. have shown that aldolase C is a
multifunctional protein which apart from its metabolic role
exhibits an endoribonuclease activity which may be associated
with viral RNA degradation and recombination [44]. Our results
have also shown a remarkable increase in aldolase C levels at later
stages of infection which may be the host response to eliminate the
viral replication. A member of the ATP synthase complex ATP5B
was also found to be down-regulated and the decreased energy
production as a result may also be a contributing factor in severe
neurodegeneration [45]. Cytosolic brain specific creatine kinase
expression was suppressed during JEV infection which may be one
of the targets for reactive oxygen species in the brain in
neurodegenerative disease [46].
ER is an essential organelle for viral replication and maturation
as evidenced by previous reports. During the process of infection, a
large amount of viral proteins are synthesized in infected cells,
where the misfolded proteins induce the ER stress response which
Figure 6. Validation of proteomic results using Immunostaining. Differential expression of selected proteins in neuron following JEV-
infection in in vivo model. Images are representative of three independent experiments.
doi:10.1371/journal.pone.0090211.g006
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modulate various signaling pathways leading to cell survival or cell
death [47]. The cellular machinery responds to this stress by
induction of molecular chaperones, enhancement of degradation
and clearance of unfolded proteins. This response is termed as
unfolded protein response (UPR) [48]. An earlier study has shown
that JEV infection triggers the UPR in fibroblast BHK-21 cells and
in neuronal N18 and NT-2 cells, which results in apoptotic cell
death [49]. Altered expression of chaperones such as glucose-
regulated proteins (GRPs), BiP/GRP78 and other ER-resident
proteins such as calreticulin and protein disulfide isomerase (PDI)
can be associated with UPR [48] which corroborate our findings.
We also observed an over expression of heat shock proteins HSP70
following JEV infection which may have a protective role against
apoptosis [10]. Our investigation reports high levels of ERP29
which is an established member of the host stress response
machinery and found to be associated with chaperones like BiP
during UPR [50]. We observed a decrease in the levels of ERP57,
a member of protein disulfide isomerase (PDI) family of foldases
which is known to participate in signaling events from the plasma
membrane as well as in regulatory events in the nucleus [51].We
report a significant decline in the levels of calreticulin (CRT), an
ER chaperone and play an important role in intracellular calcium
homeostasis, which has been shown to interact with the NS5
protein of Dengue Virus. It has also been reported to have a
possible role in flaviviral replication [52]. A decline in the levels of
T complex protein subunit epsilon (CCT5), a chaperonin
belonging to the HSP70 family of proteins was observed in the
JEV infected mouse brain. Previous reports have shown this
protein to be involved in interaction with Nonstructural protein
NS5 of Hepatitis C virus nuclear antigen aiding its replication
[51]. The down regulation of this protein may be a host defense
mechanism to arrest the viral replication. Stress-induced phos-
phoprotein 1 (STIP1) also known as heat shock protein (HSP)-
organizing protein levels were also found to be altered. Another
important aspect of the UPR is the degradation of the misfolded
proteins which involves the ubiquitin proteasome pathway. In the
current study a down regulation of the proteins Ubiquitin C-
terminal hydrolase-L1 (UCHL1) and Ubiquitin C-terminal
Figure 7. Temporal expression of selected proteins in mouse brain with disease progression. BALB/c mice of either sex were injected
with 36105 p.f.u. of JE virus of strain GP78 through tail vein. The animals were then dissected at 1, 3, and 5 day post (JEV) infection (d.p.i) and brain
was isolated for protein extraction. (A) Immunoblot showing the protein expression levels during JEV infectionas compared to that of mock-infected
control mice. (B) Densitometric analysis of the differential protein expression. Data is representative of three independent experiments.
doi:10.1371/journal.pone.0090211.g007
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hydrolase-L3 was observed. Neurodegeneration, posterior paral-
ysis and dysphagia which are some of the key symptoms of JEV
infection is associated with the loss of UCHL1 and UCHL3 [53].
Hence we may propose that the down regulation of these two
proteins may play an important role in JEV associated pathologies
but the underlying mechanism by which JEV brings about this
alteration is not known. Valosin-containing protein (VCP) was
found to be down regulated during JEV infection. Depletion or
catalytic inhibition of VCP prevents capsid degradation and
reduces neutralization by antibodies during host antiviral response
which provides a possible explanation to our findings in our study
[54]. Thus ER stress induced unfolded protein response (UPR),
triggers a unique signaling cascade from the ER to the nucleus of a
cell which activates expression of CHOP/GADD153, and appears
to trigger activation of p38 mitogen-activated protein kinase, thus
enhancing JEV-induced apoptosis [49].
In response to endoplasmic reticulum (ER) stress, an ER
membrane-anchored transcription factor known as activating
transcription factor 6 (ATF6), is transported to the Golgi apparatus
and cleaved by site-1 protease (S1P) to activate the unfolded
protein response (UPR) [55]. We observed an up-regulation of
nucleobindin 1 (NUCB1) which is a golgi-localized negative
feedback regulator in this ATF6-mediated branch of the UPR.
Thus NUCB1 up regulation may suppress the unfolded protein
response. The present study also reports an increase in the levels of
the protein proteasome subunit alpha1 (Psma1) which is a subunit
of the 20S proteasome or immunoproteasome involved in
generating immunogenic peptides for presentation to CD8 T cells
as part of immune surveillance. A recent study by Freudenburg et
al. [56], has also shown that reduction in ATP levels lead to
immunoproteasome activation during early antiviral response
mediated by IFNb in mouse pancreatic b-cells. This supports our
claim of declining levels of the glycolytic enzymes in the JEV
infected brain cells. A significant observation during our investi-
gation was the ubiquitous serum albumin expression precursor in
the brain. Recent studies have evidenced that albumin secretion is
enhanced by microglial activation [57]. Microglial activation is a
hallmark of JEV infection and these reports support the increase in
the levels of albumin following JEV infection [58].
Conclusions
In conclusion, this study provides a detailed proteomic analysis
supported by bioinformatics to suggest that JEV invades the
Figure 8. Expression of selected proteins in human neuroblastoma (SHSY 5Y) cells after JEV infection. SHSY 5Y cells were either mock-
infected or infected with JEV (4.46109 pfu/mL) at multiplicity of infection (MOI) of 5 for 1.5 h. The expression of different proteins after JEV infection
as compared to mock-infected controls was analyzed by immunoblotting. Data represented are means6 SD of three independent experiments. Dark
grey bars indicate spots from mock infected control sample while light grey bars indicate JEV infected sample * =p,0.05.
doi:10.1371/journal.pone.0090211.g008
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protein folding machinery of the host to ensure its replication and
survival within the host brain thereby inducing ER stress leading
to severe unfolded protein response. Apart from that oxidative
stress, cytoskeletal disorganization and intracellular transport were
also found to be affected during JEV infection. Our investigation
has been a groundwork study in the field of neuropathogenesis
post-JEV infection which will be of potential importance to
investigators who will be interested in conducting anti-viral
research in this field.
Supporting Information
Figure S1 Biological pathway enrichment analysis
showing biological functions associated with proteins
identified from (A) Neuro2a cells (B) Mouse brain tissue. The
red color nodes are the proteins and green nodes describes the
functional biological process. The relation between nodes was
shown by edges.
(TIF)
Figure S2 Biological pathway enrichment analysis
showing various pathways affected by the differentially
regulation of the identified proteins during JEV infection
on (A) Neuro2a cells (B) Mouse brain tissue. The red color nodes
are the proteins and green nodes describes the functional
biological process. The relations between nodes were shown by
edges.
(TIF)
Figure S3 Protein interaction network involving differ-
entially regulated proteins identified in the mouse
brain. The red color nodes are the proteins and green nodes
describes the functional biological process. The relations between
nodes were shown by edges.
(TIF)
Figure S4 Protein interaction network involving differ-
entially regulated proteins identified in the Neuro2a
cells. The red color nodes are the proteins and green nodes
describes the functional biological process. The relations between
nodes were shown by edges.
(TIF)
Figure 9. A schematic representation of the host response to JEV infection. Bioinformatic analysis of the proteins identified during the
study was carried out to identify the various pathways and biological processes involved in the virus-host interaction. Based on the derived data, JEV
pathogenesis network was constructed. Red tabs represent viral proteins and pink tabs represent the host proteins identified in this study.
doi:10.1371/journal.pone.0090211.g009
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Figure S5 The protein-protein interaction network of
unfolded protein response (UPR) associated genes encoding
Erp29, Hsp90b1, Hspa5, Pdia6, Calr and HSPA8.
(TIF)
Figure S6 Functional classification of the differentially
affected proteins during JEV infection in (A) mouse brain
tissue (B) Neuro2a cells.
(TIF)
Table S1 Antibody dilutions used for immunoblotting.
(DOC)
Table S2 Proteins showing differential expression after
JEV infection, identified by MS/MS analysis of gel
excised spots.
(DOC)
Table S3 List of identified proteins used for protein-
protein interaction analysis.
(DOC)
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